

SEARCH
QUICKLINKS AND VIEW OPITONS
Sugar-sweetened soft drinks may increase the risk of pancreatic cancer in women
Posted by .(JavaScript must be enabled to view this email address)
Monday, September 26, 2005 8:18 am Email this article
Consumption of sugar-sweetened soft drinks may increase the risk of pancreatic cancer in women, especially overweight women or women who do not exercise according to a study from the Harvard Medical School in Boston, Mass., USA. MEN
Sugar-sweetened sodas associated with 25% lower risk of pancreatic cancer risk in men, but not significant
Consumption of three or more sugar-sweetened sodas per week was associated with 25 percent lower risk of pancreatic cancer risk in men, however, the difference was not statistically significant, which means that there was more than a 5 percent chance that this is simply due to random chance.
Overweight men who consume sugar-sweetened sodas at 23% greater risk
Among overweight men, consumption of three or more sugar-sweetened sodas per week was associated with 23 percent greater risk of pancreatic cancer risk, however, the difference was not statistically significant.
DIET SODAS
Diet sodas to not increase the risk
“[C]onsumption of diet soft drinks was not associated with an elevated pancreatic cancer risk,” the researchers noted.
WOMEN
Women who drank 3 or more sugary sodas per week were 1.57 times more likely to get pancreatic cancer
Women who consumed more than three sugar-sweetened soft drinks per week were 57 percent more likely to get pancreatic cancer than women who drank sugar-sweetened sodas less than once a month.
OVERWEIGHT WOMEN
Overweight women who drank sugar-sweetened sodas 1.89 times greater risk
Among overweight women, that is those with a body mass index (BMI) greater than 25, drinking three or more sugary sodas per week increased the risk 89 percent.
NON-EXERCISING WOMEN
Non-exercising women who drank sugar-sweetened sodas 2 times greater risk
And among women who did not get much exercise, those who consume three or more sugar-sweetened sodas per week were twice as likely to get pancreatic cancer, an increased risk of 102 percent or 2.02 times greater risk than those who rarely or never consumed them.
Diabetes and high glycemic loads risk factors for pancreatic cancer
“A history of diabetes mellitus and a diet high in glycemic load are both potential risk factors for pancreatic cancer,” the researchers noted.
“Sugar-sweetened soft drinks are a prevalent source of readily absorbable sugars and have been associated with an increased risk of obesity and diabetes.”
RISK PER SODA
Every sugar-sweetened soda per day increases risk 19% in women
Every additional sugar-sweetened soda consumed each day was associated with a 19 percent greater risk of pancreatic cancer in women, but a 10 percent lower risk in men.
SUBJECTS
Subjects: 88,794 women and 49,364 men followed for 20 years
The study followed 88,794 women from the Nurses’ Health Study and 49,364 men from the Health Professionals Follow-up Study without cancer when the studies began and followed them for 20 years.
379 cases of pancreatic cancer during 20-year follow-up
There were 379 cases of pancreatic cancer during up to 20 years of follow-up, 205 women and 174 men.
CONCLUSION
Conclusion: Greater risk among women and people who are overweight
“[O]ur data may suggest a modestly higher pancreatic cancer risk associated with higher consumption of sugar-sweetened soft drinks among women as well as those who are overweight,” the authors concluded.
PANCREATIC CANCER STATISTICS
Pancreatic cancer rapidly fatal; fourth leading cause of cancer-related death in the U.S.
Pancreatic cancer is the fourth leading cause of cancer-related death in the U.S., is usually rapidly fatal with little effective treatments according to the paper.
REFERENCE
Schernhammer ES, Hu F, Giovannucci E, Michaud D, Colditz G, Stampfer M, Fuchs CS. Sugar-sweetened soft drink consumption and risk of pancreatic cancer in two prospective cohorts. Cancer Epidemiol Biomarkers Prev. 2005 Sep, 14(9):2098-105.
AUTHOR’S CONTACT INFORMATION
Eva Schernhammer
Channing Laboratory
Department of Medicine
Brigham and Women’s Hospital
and
Harvard Medical School
Boston, MA 02115, USA
.(JavaScript must be enabled to view this email address)
Articles on the same subject can be found here:
COMMENTS
Please feel free to share your comments about this article.
© Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.